human | Q5 |
P735 | given name | Robert | Q4927937 |
Robert | Q4927937 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q34140192 | A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitis |
Q37660241 | A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis |
Q40009124 | Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling |
Q37865031 | An update on molecular research of pancreatic adenocarcinoma |
Q34475611 | Association studies of the copy-number variable ß-defensin cluster on 8p23.1 in adenocarcinoma and chronic pancreatitis |
Q35738861 | Blood Glucose Homeostasis in the Course of Partial Pancreatectomy--Evidence for Surgically Reversible Diabetes Induced by Cholestasis |
Q34285030 | Chronic pancreatitis of the pancreatic remnant is an independent risk factor for pancreatic fistula after distal pancreatectomy |
Q28243334 | Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer |
Q34727314 | DNA methylation biomarkers for blood-based colorectal cancer screening |
Q37987512 | DNA methylation in pancreatic cancer: protocols for the isolation of DNA and bisulfite modification |
Q35959313 | DNA microarray analysis of pancreatic malignancies |
Q38852806 | Effect of Hospital Volume on In-hospital Morbidity and Mortality Following Pancreatic Surgery in Germany |
Q40637929 | Evaluation of central pancreatectomy and pancreatic enucleation as pancreatic resections--A comparison |
Q34680864 | Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma |
Q33680539 | Examination of apoptosis signaling in pancreatic cancer by computational signal transduction analysis |
Q31061871 | Feedback within the inter-cellular communication and tumorigenesis in carcinomas |
Q39522586 | Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method |
Q39763088 | Functional analysis of LOXL2 in pancreatic carcinoma |
Q40404112 | Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer |
Q36919864 | Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome |
Q34928555 | Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays |
Q34292747 | Genetic analyses of heme oxygenase 1 (HMOX1) in different forms of pancreatitis |
Q40103441 | Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis |
Q38791499 | Genomic analyses identify molecular subtypes of pancreatic cancer |
Q34276961 | Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes |
Q34553313 | Improved protocol for laser microdissection of human pancreatic islets from surgical specimens |
Q38755196 | Influence of Hospital Volume Effects and Minimum Caseload Requirements on Quality of Care in Pancreatic Surgery in Germany |
Q39804553 | Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells |
Q35497551 | Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers |
Q35593104 | Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis |
Q35583848 | Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment |
Q38764462 | Isolation of human islets from partially pancreatectomized patients |
Q36179367 | Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis |
Q30989925 | Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes |
Q35639853 | Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives |
Q38166586 | Molecular pathogenesis of pancreatic neuroendocrine tumors |
Q40057963 | Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients |
Q39919567 | Nationwide In-hospital Mortality Following Pancreatic Surgery in Germany is Higher than Anticipated |
Q37230982 | Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience |
Q37507740 | Pancreatic acinar cell carcinoma: a multi-institutional study |
Q38830793 | Pathogenic, immunologic, and clinical aspects of sepsis - update 2016. |
Q34661643 | Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. |
Q39267521 | Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction |
Q39709258 | Primary and recurrent sporadic desmoids: Prognostic factors influencing recurrence-free survival after complete gross resection |
Q38240842 | Prognostic relevance of minimal residual disease in colorectal cancer |
Q39824226 | Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma |
Q39267056 | Quality of life in patients after pancreaticoduodenectomy for chronic pancreatitis |
Q37348003 | Recent patents concerning diagnostic and therapeutic applications of aberrantly methylated sequences in pancreatic cancer |
Q37824885 | Recent patents concerning targeted therapy of apoptosis resistance in pancreatic cancer |
Q33514463 | Search for and identification of novel tumor-associated autoantigens |
Q21090079 | Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay |
Q38166573 | Serum tumor markers in pancreatic cancer-recent discoveries |
Q33636816 | Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis |
Q36782324 | Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy |
Q37612348 | Solid pseudopapillary neoplasms of the pancreas: a multi-institutional study of 21 patients |
Q31119505 | Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data |
Q38668745 | Survival analysis in rectal carcinoma after neoadjuvant chemoradiation: various methods with different results |
Q28297342 | Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer |
Q30930877 | Systematic isolation of genes differentially expressed in normal and cancerous tissue of the pancreas |
Q36257567 | The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation |
Q36036234 | The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma |
Q33362834 | Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer |
Q37540036 | Variants in CPA1 are strongly associated with early onset chronic pancreatitis |
Q39251591 | What is Changing in Indications and Treatment of Focal Nodular Hyperplasia of the Liver. Is There Any Place for Surgery? |
Q35911034 | Whole genomes redefine the mutational landscape of pancreatic cancer |
Search more.